Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LifeStance Health Group Inc. Common Stock (LFST) vs 10X Genomics Inc (TXG) Price & Performance

LifeStance Health Group Inc. Common StockTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

LifeStance Health Group Inc. Common Stock vs 10X Genomics Inc — how do they compare? LifeStance Health Group Inc. Common Stock trades at $12.42 (market cap $4.58B), while 10X Genomics Inc trades at $80.87 (market cap $10.07B). The key difference: 10X Genomics Inc is far larger — about 2.2× LifeStance Health Group Inc. Common Stock's market cap, and 10X Genomics Inc is more actively traded (5,657,286 versus 2,356,698). Which is the better fit depends on your goals — on Pluang, investors hold LifeStance Health Group Inc. Common Stock for 1 Days and 10X Genomics Inc for 91 Days on average.

LFSTTXG
Market Cap
$4.58B$10.07B
Volume
2,356,6985,657,286
Sector
HealthHealth
52-Week High
$13.38$97.74
52-Week Low
$4.81$11.48
Typical Hold Time
1 Days91 Days
Enterprise Value
$4.82B$9.59B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

LifeStance Health Group Inc. Common Stock

No Aura AI signal available yet.

10X Genomics Inc

10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.

The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LFST

No sentiment data available yet.

TXG
97% Buy3% Sell
Avg holding period · 91 Days

Top news

Latest headlines on both assets

About LifeStance Health Group Inc. Common Stock

LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.

Read more on LFST →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →